Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel vs Combinations in 2nd-line Metastatic Gastric Cancer
NCT00980603Phase 2Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Nov 2008
- Primary completion
- Nov 2010
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), tegafur in gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00980603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980603.